Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

319
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
319
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

524
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
524
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

79
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
79
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

119
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
119
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

209
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
209
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

444
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
444

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A novel design using a virtual control group to evaluate non-inferiority of nevirapine and lamivudine dual maintenance in HIV therapy.

PloS one·2026
Same author

Focus on MAIT cell antigens fueling biliary liver injury.

Cellular and molecular gastroenterology and hepatology·2026
Same author

Comparison of self-collected oral swabs for supragingival microbiome characterization using 16S rRNA gene amplicon sequencing.

Journal of microbiological methods·2026
Same author

Early antifungal resistance prediction based on MALDI-TOF mass spectrometry and machine learning.

Scientific reports·2026
Same author

The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the European Committee on Antimicrobial Susceptibility Testing Subcommittee.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

A global economic perspective on whole-genome sequencing strategies for pathogens: continuous surveillance versus outbreak-triggered investigations.

The Lancet. Microbe·2026

相关实验视频

Updated: May 27, 2025

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

273

[螺旋杆菌] [螺旋杆菌]

Fabian Egli1, Dominik Dill1, Baharak Babouee Flury2

  • 1Universitäres Zentrum Innere Medizin, Infektiologie und Spitalhygiene, Kantonsspital Baselland, Bruderholz, Universität Basel.

Praxis
|February 18, 2025
PubMed
概括
此摘要是机器生成的。

杆菌 (HP) 感染需要治疗以预防和癌症. 在开始治疗之前,耐药性测试至关重要,因为抗菌素耐药性日益增加,特别是在移民群体中.

关键词:
在Helicobacter Pylori的研究中,抗微生物耐药性 抗微生物耐药性十二指甲的.根除,查和除的方法.胃癌 (胃癌) 是一种胃癌.胃潰瘍 胃潰瘍 胃潰瘍

更多相关视频

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
09:05

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

15.1K
One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
10:44

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

9.6K

相关实验视频

Last Updated: May 27, 2025

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

273
High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
09:05

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

15.1K
One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
10:44

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

9.6K

科学领域:

  • 胃肠病学 胃肠病学
  • 传染性疾病 传染性疾病
  • 微生物学 微生物学

背景情况:

  • 杆菌 (HP) 是一种持久性细菌感染.
  • 肝炎感染与胃和十二指肠以及胃癌有关.
  • 肝炎发病率正在下降,但在某些人群中仍然很高,比如移民.

研究的目的:

  • 强调需要对HP感染进行一致的治疗.
  • 强调在开始HP治疗之前进行抗菌素耐药性测试的重要性.
  • 为了应对HP管理指南不断变化的格局.

主要方法:

  • 审查目前的临床指南和HP的流行病学数据.
  • 分析抗菌素耐药性对治疗疗效的影响.
  • 对诊断和治疗策略的建议.

主要成果:

  • 肝炎感染不是短暂的,需要治疗.
  • 对HP的抗菌素耐药性是一个越来越令人担忧的问题.
  • 建议在一线HP治疗前进行抗药性测试.

结论:

  • 持续治疗HP感染对于预防严重的胃肠道并发症至关重要.
  • 抗微生物耐药性需要治疗前进行耐药性测试,以有效地根除HP.
  • 鉴于HP患病率和耐药性模式的变化,更新的管理策略至关重要.